IS5582A - Meta-azahringaminobenzoic acid compounds and their derivatives prove to be antagonists of integrin. - Google Patents

Meta-azahringaminobenzoic acid compounds and their derivatives prove to be antagonists of integrin.

Info

Publication number
IS5582A
IS5582A IS5582A IS5582A IS5582A IS 5582 A IS5582 A IS 5582A IS 5582 A IS5582 A IS 5582A IS 5582 A IS5582 A IS 5582A IS 5582 A IS5582 A IS 5582A
Authority
IS
Iceland
Prior art keywords
azahringaminobenzoic
integrin
antagonists
meta
acid compounds
Prior art date
Application number
IS5582A
Other languages
Icelandic (is)
Inventor
E. Rogers Thomas
G. Ruminski Peter
Original Assignee
G.D. Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G.D. Searle & Co filed Critical G.D. Searle & Co
Publication of IS5582A publication Critical patent/IS5582A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5582A 1998-03-04 2000-08-04 Meta-azahringaminobenzoic acid compounds and their derivatives prove to be antagonists of integrin. IS5582A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3427098A 1998-03-04 1998-03-04
PCT/US1999/003281 WO1999044994A1 (en) 1998-03-04 1999-02-22 Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists

Publications (1)

Publication Number Publication Date
IS5582A true IS5582A (en) 2000-08-04

Family

ID=21875345

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5582A IS5582A (en) 1998-03-04 2000-08-04 Meta-azahringaminobenzoic acid compounds and their derivatives prove to be antagonists of integrin.

Country Status (29)

Country Link
EP (1) EP1060164A1 (en)
JP (1) JP2002505323A (en)
KR (1) KR20010041584A (en)
CN (1) CN1214011C (en)
AP (1) AP1244A (en)
AR (1) AR018139A1 (en)
AU (1) AU753230B2 (en)
BG (1) BG104740A (en)
BR (1) BR9908470A (en)
CA (1) CA2322207A1 (en)
EA (1) EA200000804A1 (en)
EE (1) EE200000506A (en)
GE (1) GEP20033118B (en)
HR (1) HRP20000574A2 (en)
HU (1) HUP0100865A3 (en)
ID (1) ID25591A (en)
IL (1) IL137653A0 (en)
IS (1) IS5582A (en)
MY (1) MY123908A (en)
NO (1) NO315703B1 (en)
NZ (1) NZ506598A (en)
OA (1) OA11530A (en)
PL (1) PL342726A1 (en)
SK (1) SK13002000A3 (en)
TR (1) TR200002542T2 (en)
UA (1) UA71906C2 (en)
WO (1) WO1999044994A1 (en)
YU (1) YU52000A (en)
ZA (1) ZA994406B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
DE60130910T2 (en) 2000-04-17 2008-07-10 Ucb Pharma, S.A. ENAMINE DERIVATIVES AS CELL ADHESION MOLECULES
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6921767B2 (en) * 2000-06-15 2005-07-26 Pharmacia Corporation Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
CA2417059A1 (en) 2000-08-02 2002-02-07 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
EP1572210A1 (en) * 2002-12-20 2005-09-14 Pharmacia Corporation The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
AU2006257815A1 (en) * 2005-06-10 2006-12-21 Bipar Sciences, Inc. PARP modulators and treatment of cancer
EP2131861A2 (en) 2007-03-01 2009-12-16 Mallinckrodt Inc. Integrated photoactive small molecules and uses thereof
JP4792124B1 (en) * 2010-11-15 2011-10-12 エフイートレード株式会社 Method for molding protective film for vehicle and method for manufacturing protective film for vehicle
IN2015DN00099A (en) 2012-07-18 2015-05-29 Univ Saint Louis
US8716226B2 (en) 2012-07-18 2014-05-06 Saint Louis University 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
ES2864079T3 (en) 2014-05-30 2021-10-13 Pfizer Carbonitrile derivatives as selective androgen receptor modulators
WO2015187774A1 (en) * 2014-06-04 2015-12-10 Monsanto Technology Llc 3,6-dichlorosalicylic acid compounds and related synthetic processes
HK1244806A1 (en) 2015-12-30 2018-08-17 Saint Louis University Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
JP7661969B2 (en) 2020-05-14 2025-04-15 Ube株式会社 1,4,5,6-Tetrahydropyrimidin-2-amine derivatives
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
JPWO2023085396A1 (en) 2021-11-12 2023-05-19

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9801716A (en) * 1995-08-30 1998-05-31 Searle & Co Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists.

Also Published As

Publication number Publication date
BR9908470A (en) 2000-12-05
ID25591A (en) 2000-10-19
TR200002542T2 (en) 2001-05-21
MY123908A (en) 2006-06-30
PL342726A1 (en) 2001-07-02
NZ506598A (en) 2003-07-25
JP2002505323A (en) 2002-02-19
NO20004316D0 (en) 2000-08-30
NO315703B1 (en) 2003-10-13
SK13002000A3 (en) 2001-07-10
EE200000506A (en) 2002-04-15
AU3294799A (en) 1999-09-20
EP1060164A1 (en) 2000-12-20
AP1244A (en) 2004-02-04
EA200000804A1 (en) 2001-04-23
HUP0100865A3 (en) 2001-11-28
KR20010041584A (en) 2001-05-25
ZA994406B (en) 2000-02-11
GEP20033118B (en) 2003-11-25
CA2322207A1 (en) 1999-09-10
AR018139A1 (en) 2001-10-31
WO1999044994A1 (en) 1999-09-10
YU52000A (en) 2003-02-28
IL137653A0 (en) 2001-10-31
NO20004316L (en) 2000-11-06
CN1291978A (en) 2001-04-18
OA11530A (en) 2004-05-17
CN1214011C (en) 2005-08-10
HUP0100865A2 (en) 2001-08-28
BG104740A (en) 2001-02-28
AU753230B2 (en) 2002-10-10
HRP20000574A2 (en) 2001-08-31
UA71906C2 (en) 2005-01-17
AP2000001893A0 (en) 2000-09-30

Similar Documents

Publication Publication Date Title
ATE299503T1 (en) PYRIDINE-3-CARBONIC ACID DERIVATIVES AND THEIR USE AS INTERMEDIATE PRODUCTS
DE60123210D1 (en) PICOLIC ACID DERIVATIVES AND THEIR USE AS FUNGICIDES
EE200200251A (en) Novel N-azabicycloamide derivatives and their use
IS5744A (en) New 3-aryl-propionic acid derivatives and analogues
DE60133897D1 (en) SUBSTITUTED CHINAZOLIN DERIVATIVES AND THEIR USE AS AURORA-2-KINASE INHIBITORS
EE200000506A (en) Meta-azacyclic aminobenzoic acid compounds and their derivatives as integrin antagonists
PT1140191E (en) COMBINATIONS OF INHIBITORS OF TRANSPORT OF BILIARY ACID AND NICOTYNIC ACID DERIVATIVES USED IN THE CARDIOVASCULAR PERTURBACLE FRAMEWORK
DK1165516T3 (en) Heterocyclic urea and related compounds useful as anti-inflammatory agents
EE200100403A (en) Indole derivatives and their use as MCP-1 antagonists
DE60036803D1 (en) ARYLMETHYL-CARBONYLAMINO-THIAZONE DERIVATIVES AND THEIR USE AS ANTITUM-MEANS
EE200100373A (en) Benzoheterocycles and their use as MEK inhibitors
DE69904073D1 (en) OXIME DERIVATIVES AND THEIR USE AS LATENT ACID
FI20000677A7 (en) Oxime derivatives and their use as latent acids
DE69940970D1 (en) ROLLING CIRCLE REPLICATION OF PADLOCK PROBES
AR028280A1 (en) DERIVATIVES OF 2-AMINO-3- (RENT) -PIRIMIDONA
ATE357443T1 (en) DIHYDROBENZODIOXINECARBONIC ACID AMIDE AND KETONE DERIVATIVES AS 5-HT4 RECEPTOR ANTAGONISTS
NO20013665L (en) Potassium salt of (S) -omeprazole
EE200100131A (en) Improved stability of injection solutions
IS5562A (en) New dihydroxyhexanoic acid derivatives
EE200200135A (en) Thienoisoxazolyl and thienylpyrazolylphenoxy-substituted propyl derivatives acting as D4 antagonists
DE69510228D1 (en) PIPERIDINESSIGIC ACID DERIVATIVES AND THEIR USE AS FIBRINOGENIC ANTAGONIST AGENTS
DE60008807D1 (en) Binaphthol-mono phosphoric acid derivatives and their use
DE50008549D1 (en) TRIAZOLOTRIAZINONE AND THEIR USE
IS2607B (en) Derivatives of tryptamine and analogous compounds together with their prescriptions
DE69908614D1 (en) PRODUCTION OF N-SUBSTITUTED HYDROXYCYCLOALKYLAMINE DERIVATIVES